Two Pivotal Phase 3 Trials of Proteostasis’ CF Triple Combo Therapy to Open in 2020
Proteostasis Therapeutics announced plans to open two Phase 3 clinical trials of its triple combination therapy candidate for cystic fibrosis this year, after a meeting with the chief healthcare regulatory office for the U.K. One of these pivotal trials will be investigating the possibility of organoids being used for personalized…